首页> 外文期刊>Drug delivery and translational research >In vivo comparison of biomineralized scaffold-directed osteogenic differentiation of human embryonic and mesenchymal stem cells
【24h】

In vivo comparison of biomineralized scaffold-directed osteogenic differentiation of human embryonic and mesenchymal stem cells

机译:生物矿化支架定向成骨分化人类胚胎和间充质干细胞的体内比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human pluripotent stem cells such as embryonic stem cells (hESCs) and multipotent stem cells like mesenchymal stem cells (hMSCs) hold great promise as potential cell sources for bone tissue regeneration. Comparing the in vivo osteogenesis of hESCs and hMSCs by biomaterial-based cues provides insight into the differentiation kinetics of these cells as well as their potential to contribute to bone tissue repair in vivo. Here, we compared in vivo osteogenic differentiation of hESCs and hMSCs within osteoinductive calcium phosphate (CaP)-bearing biomineralized scaffolds that recapitulate a bone-specific mineral microenvironment. Both hESCs and hMSCs underwent osteogenic differentiation responding to the biomaterial-based instructive cues. Furthermore, hMSCs underwent earlier in vivo osteogenesis compared to hESCs, but both stem cell types acquired a similar osteogenic maturation by 8 weeks of implantation.
机译:人类多能干细胞,如胚胎干细胞(hESCs)和多能干细胞,如间充质干细胞(hMSCs),具有作为骨组织再生的潜在细胞来源的巨大希望。通过基于生物材料的线索比较hESCs和hMSC的体内成骨作用,可以洞悉这些细胞的分化动力学及其对体内骨组织修复的潜力。在这里,我们比较了骨诱导矿物质微环境的骨诱导磷酸钙(CaP)的生物矿化支架内hESCs和hMSCs的体内成骨分化。 hESCs和hMSCs都经历了成骨分化,以响应基于生物材料的指导性提示。此外,与hESC相比,hMSC在体内发生了早期成骨作用,但是两种干细胞类型在植入8周后都获得了相似的成骨成熟性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号